Syndax Pharmaceuticals, Inc.
SNDX
$23.94
$0.441.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 49.83% | 60.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 49.83% | 20.85% | |||
| Cost of Revenue | 39.34% | -8.07% | |||
| Gross Profit | -0.88% | 51.04% | |||
| SG&A Expenses | 12.05% | 2.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.47% | -3.74% | |||
| Operating Income | -9.62% | 17.20% | |||
| Income Before Tax | -12.68% | 15.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.02% | 15.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.02% | 15.49% | |||
| EBIT | -9.62% | 17.20% | |||
| EBITDA | -9.61% | 17.20% | |||
| EPS Basic | -11.66% | 15.78% | |||
| Normalized Basic EPS | -12.30% | 15.77% | |||
| EPS Diluted | -11.66% | 15.78% | |||
| Normalized Diluted EPS | -12.30% | 15.77% | |||
| Average Basic Shares Outstanding | 0.33% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.33% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||